Siderophore-Enabled Delivery of Carbapenem and Metallo-β-Lactamase Inhibitor: A Promising Strategy against Multidrug-Resistant Pseudomonas aeruginosa
In the authors' words
Abstract Carbapenem-resistant Pseudomonas aeruginosa (CRPA), a World Health Organization high-priority pathogen, represents a major clinical threat due to limited treatment options. Its intrinsic resistance is driven in part by extremely low outer-membrane permeability, which restricts antibiotic uptake, while the increasing prevalence of metallo-β-lactamase (MBL)-producing strains, particularly NDM-expressing isolates, poses a critical therapeutic challenge, conferring resistance to both carbapenems and cefiderocol, with few effective inhibitors available. In this study, we evaluated the potential of a series of unique biomimetic siderophore conjugates in combating CRPA. As an initial approach, tris-catecholate siderophore–meropenem conjugates were synthesized and demonstrated to overcome nonenzymatic carbapenem resistance in P. aeruginosa, including porin loss and efflux upregulation, in an iron-dependent manner. We then targeted MBL-expressing CRPA by vectorizing a recently developed broad-spectrum MBL inhibitor, indole carboxylates (InC), which is largely ineffective against P. aeruginosa, likely due to poor permeability. These conjugates restored inhibitor activity and effectively reversed meropenem and cefiderocol resistance in MBL-producing clinical isolates, both in vitro and in a Galleria mellonella infection model. Together, these findings highlight the design and potential of siderophore conjugates as a versatile platform to revive the efficacy of life-saving antibiotics against multidrug-resistant Gram-negative pathogens.
In plain words AI summary
These conjugates overcame resistance caused by porin loss and efflux pumps in Pseudomonas aeruginosa. They also attached siderophores to an inhibitor called indole carboxylates, which normally cannot enter this bacterium. The new conjugates restored the inhibitor's activity and reversed resistance to meropenem and cefiderocol in lab tests and in infected wax moth larvae. The authors suggest siderophore conjugates could be a flexible way to make existing antibiotics work against drug-resistant bacteria again.
Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source. 1 sentence was removed for not being supported by the abstract.
Appeared: Tuesday, September 29. Journal of the American Chemical Society. Peer-reviewed journal.
DOI: 10.1021/jacs.6c08350